FAQ's

Frequently Asked Questions (FAQs)

For donors

 

1. What is Regenerative Medicine?

Regenerative Medicine harnesses the power of stem cells to repair, regenerate or replace diseased cells, tissues and organs. For more information, visit What is Regenerative Medicine?

 
 

2. What regulations govern stem cell research at the McEwen Centre?

The McEwen Centre adheres to all institutional and national regulations governing stem cell research in Canada.

Research Ethics Boards

All research conducted at the McEwen Centre which involves human cells or tissues requires prior review and approval by the Research Ethics Board at the institution involved. For example, human stem cell research conducted at University Health Network (UHN) requires the prior approval of UHN’s Research Ethics Board. In addition to Research Ethics Board approval, all research in Canada involving human pluripotent stem cells must adhere to the guidelines described below.

National Guidelines for Stem Cell Research

The Canadian Institutes of Health Research (CIHR), Canada’s largest funding agency for health research, has established Guidelines for Human Pluripotent Stem Cell Research. These guidelines have been adopted by Canada’s three largest research funding agencies: CIHR, the Natural Sciences and Engineering Research Council (NSERC) and the Social Sciences and Humanities Research Council (SSHRC). The Guidelines require all research proposals in Canada which involve human pluripotent stem cells to be reviewed by a Stem Cell Oversight Committee before proceeding. The Committee’s members include experts in ethics, stem cell biology, law, and social sciences, as well as representatives of the general public. For more information, visit CIHR http://www.cihr-irsc.gc.ca

 
 

3. What regulations govern stem cell research in other countries?

Regulations governing stem cell research differ from country to country. The International Society for Stem Cell Research provides an overview of legislation governing human embryonic stem cell research in various countries: http://isscr.org/public/regions/index.cfm

 
 

4. What regenerative medicine therapies are currently being used to treat patients?

Hematopoietic stem cell transplantation (i.e. a bone marrow tranplant) is a cell therapy procedure that has routinely been used for over 30 years in the treatment of patients with blood diseases such as leukemia. Currently, there are no other approved and routine regenerative medicine therapies. New regenerative medicine therapies are being tested in pre-clinical and clinical studies around the world.

 
 

5. How is the McEwen Centre funded?

The McEwen Centre for Regenerative Medicine was founded and launched with two generous gifts from Rob and Cheryl McEwen (see News & Events). Other individuals and organizations have made exemplary gifts in support or the Centre (see Thanking Our Donors). The team of McEwen Investigators continues to secure research grants from funding agencies to support the infrastructure and operations needs of their labs.

 
 

6. Why is my financial support important?

Your donation will help launch new research projects, attract and retain top-tier researchers and outfit new, world-class lab facilities. For an innovative, leading-edge research area like regenerative medicine, private donor support is a critical cornerstone for success. For more information or to make a donation, please see Getting Involved.

 
 

7. How can I be sure my donation is being used to support research?

Your donation is administered by Toronto General & Western Hospital Foundation, which has strict guidelines for accountability and donor reporting. For more information, please see Getting Involved or visit www.tgwhf-uhn.ca

If you have a question about the McEwen Centre you don’t see reflected here, please Contact Us.